JB’s absolute Scope1 & Scope2 emissions reduced by 13.9 % in the last financial year, despite turnover increasing by 11%
WEF recognises company’s Bharuch manufacturing facility as a global manufacturing lighthouse
The report highlights Piramal Pharma’s approach across four key strategic pillars: Responsible Operations, Business Resilience, Customer Centricity, and Quality & Excellence
The net-zero target approval complements the company's near-term emission reduction targets
Aragen Life Sciences is the first Indian CRDMO to receive SBTi approval
MoU signed to drive digital transformation through strategic projects across all three business sectors of Merck
This validation aligns with Piramal Pharma's core purpose of 'Doing Well and Doing Good,'
Investment in new plant meets increasing demand for functional excipients for oral drug delivery
The new bioeconomy policy rolled out by the Modi government is set to place India as a global leader in the years to come
Q1 Consolidated operating profit Up 8.3%; revenue grows 7% to Rs 3,349 crore
Subscribe To Our Newsletter & Stay Updated
